DepoMed, Inc. (DEPO) Misses Q2 on Top and Bottom
Tweet Send to a FriendGet Alerts DEPO Hot Sheet
Price: $5.72 -0.35%
Revenue Growth %: +56.0%
Financial Fact:
License and collaborative revenue: 2.96M
Today's EPS Names:
DSX, REDF, REX, More
Revenue Growth %: +56.0%
Financial Fact:
License and collaborative revenue: 2.96M
Today's EPS Names:
DSX, REDF, REX, More
Trade DEPO Now!
DepoMed, Inc. (NASDAQ: DEPO) reported Q2 EPS of ($0.28), $0.07 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $14.1 million versus the consensus estimate of $16.73 million.
For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- China Digital TV Holding Co. (STV) Improves Q1 EPS to 13c
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
